Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 75

Results For "S-1"

785 News Found

HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY
Healthcare | August 13, 2021

HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY

Substantial reduction in losses


Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22
News | August 12, 2021

Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22

Income declines marginally


Natco Pharma PAT at Rs 75 crore for Q1FY22
News | August 12, 2021

Natco Pharma PAT at Rs 75 crore for Q1FY22

The company has strong product launches both in India and overseas


Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22
News | August 11, 2021

Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22

The company has tied up with OrbiMed as a financial partner for global reach


Lupin posts net profit of Rs 542.46 cr. in Q1FY22
News | August 11, 2021

Lupin posts net profit of Rs 542.46 cr. in Q1FY22

The profits were bolstered by the Boehringer Ingelheim MEK program income


Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22
News | August 11, 2021

Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22

Formulation business grew by 15 per cent in the quarter


Krishna Institute of Medical Sciences PAT at Rs 89.12 cr for Q1FY22
News | August 11, 2021

Krishna Institute of Medical Sciences PAT at Rs 89.12 cr for Q1FY22

KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021


Amring Pharmaceuticals launch Isoproterenol Hydrochloride Injection USP
News | August 10, 2021

Amring Pharmaceuticals launch Isoproterenol Hydrochloride Injection USP

The drug is indicated for mild and transient episodes of heart block


Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal Dx Lung and Colon Cancer Assay
Drug Approval | August 10, 2021

Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal Dx Lung and Colon Cancer Assay

The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients